The Conference Forum announced the launch of the 2025 CRAACO®: Clinical Research as a Care Option event, focused on getting the option of clinical research closer to where patient care takes...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", "NRx" or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"), a...

Biolexis Therapeutics, Inc. (www.biolexistx.com), a clinical-stage therapeutics company pioneering next-generation treatments for metabolic and muscle-wasting diseases, today announced the...

Experts gathered to share challenges and solutions facing the crop protection industry WESTMINSTER, Colo., June 12, 2025 /PRNewswire/ -- Several Weed Science Society of America (WSSA) members...

Data demonstrates that pozdeutinurad alone or in combination achieves significant reduction in sUA levels in patients with tophaceous gout up to 18 months of treatment Pozdeutinurad's long-term...